Healthcare -
Biotechnology - NASDAQ - US
$ 9.61
-17.1 %
$ 482 M
Market Cap
-3.28
P/E
RGNX - NET INCOME
Net Income RGNX - REGENXBIO Inc.
-227 M
LAST VALUE
9.99%
2 YEAR CAGR
-19.11%
5 YEAR CAGR
-49.76%
10 YEAR CAGR